NCT02248883View on ClinicalTrials.gov

Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2006

Conditions
Healthy
Interventions
DRUG

TPV low

DRUG

Placebo

DRUG

Moxifloxacin

DRUG

TPV high

DRUG

RTV

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY